Published December 13, 2012
| Version v1
Patent
Open
Modulation of Cell Barrier Dysfunction
Creators
- 1. University of Chicago
Contributors
Description
The invention provides prophylactic and therapeutic methods for administering a μ-opioid receptor antagonist, e.g., N-methylnaltrexone or a salt thereof, to treat cell barrier diseases and disorders, such as endothelial and epithelial cell barrier diseases and disorders, e.g., inflammatory bowel disease. Methods of reducing the symptoms of inflammatory bowel disease and the risk of developing inflammatory bowel disease are also provided.
Files
US20120316190.pdf
Files
(4.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:a9afa16e7a2d598834ae7d3a1de1d8f2
|
4.0 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201213483932 A
- Patent application number
- US 2012/0316190 A1
- Other
- oai:uchicago.tind.io:8458
Dates
- Patent filed
-
2012-05-30